Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma - PubMed (original) (raw)
Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma
P G Pelicci et al. Proc Natl Acad Sci U S A. 1986 May.
Abstract
We have examined the position of the chromosomal breakpoint relative to the human c-myc gene (MYC) and the presence of other structural alterations of the same locus in 19 fresh samples of Burkitt lymphoma (BL) and 13 BL-derived cell lines. This panel includes the two pathogenetic forms of BL: the endemic (African-type) BL (eBL) and sporadic (American-type) BL (sBL). In all cases tested, including fresh samples and cell lines, structural alterations of the 5' portion of the gene were detected, suggesting that they may be necessary for c-myc activation. However, the site of chromosomal breakpoint and the type of structural alterations differ in eBL and sBL. In 16 of 18 sBL cases, chromosomal translocation truncates the gene within a 5' region that includes the first intron, the first exon, and 5' flanking sequences. Conversely, in 14 of 14 eBL samples, the chromosomal breakpoint is located outside the c-myc locus, yet the same 5' sequences are affected by several mutations identifiable by restriction enzyme polymorphisms. Different genetic mechanisms may therefore be involved in chromosomal translocation/c-myc activation, and these differences may be a function of differences in the stage of differentiation of eBL versus sBL.
Similar articles
- Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.
Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I. Shiramizu B, et al. Blood. 1991 Apr 1;77(7):1516-26. Blood. 1991. PMID: 1849033 - Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.
Neri A, Barriga F, Knowles DM, Magrath IT, Dalla-Favera R. Neri A, et al. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2748-52. doi: 10.1073/pnas.85.8.2748. Proc Natl Acad Sci U S A. 1988. PMID: 2833750 Free PMC article. - Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions.
Gutiérrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, Epelman S, Risueño C, Magrath IT. Gutiérrez MI, et al. Blood. 1992 Jun 15;79(12):3261-6. Blood. 1992. PMID: 1317726 - Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
Klein G. Klein G. AIDS Res. 1986 Dec;2 Suppl 1:S167-76. AIDS Res. 1986. PMID: 3030345 Review. - Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG, Siebert R, Kluin PM, Baudis M. Boerma EG, et al. Leukemia. 2009 Feb;23(2):225-34. doi: 10.1038/leu.2008.281. Epub 2008 Oct 16. Leukemia. 2009. PMID: 18923440 Review.
Cited by
- Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants.
Rochford R. Rochford R. Ann Lymphoma. 2021 Sep;5:22. doi: 10.21037/aol-21-18. Epub 2021 Sep 30. Ann Lymphoma. 2021. PMID: 34888589 Free PMC article. - Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.
Lap CJ, Nassereddine S, Dunleavy K. Lap CJ, et al. Curr Treat Options Oncol. 2021 Jun 7;22(7):60. doi: 10.1007/s11864-021-00857-w. Curr Treat Options Oncol. 2021. PMID: 34097157 Review. - Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma.
Wang HY, Sokol ES, Goodman AM, Feldman AL, Mulroney CM. Wang HY, et al. Front Oncol. 2021 Mar 10;11:620435. doi: 10.3389/fonc.2021.620435. eCollection 2021. Front Oncol. 2021. PMID: 33777766 Free PMC article. - EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.
Wilson JB, Manet E, Gruffat H, Busson P, Blondel M, Fahraeus R. Wilson JB, et al. Cancers (Basel). 2018 Apr 6;10(4):109. doi: 10.3390/cancers10040109. Cancers (Basel). 2018. PMID: 29642420 Free PMC article. Review. - EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
Dojcinov SD, Fend F, Quintanilla-Martinez L. Dojcinov SD, et al. Pathogens. 2018 Mar 7;7(1):28. doi: 10.3390/pathogens7010028. Pathogens. 2018. PMID: 29518976 Free PMC article. Review.
References
- J Natl Cancer Inst. 1980 Mar;64(3):477-83 - PubMed
- Cell. 1985 Sep;42(2):589-97 - PubMed
- N Engl J Med. 1981 Sep 24;305(13):735-45 - PubMed
- Nature. 1982 Jul 29;298(5873):474-6 - PubMed
- J Immunol. 1982 Sep;129(3):1336-42 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources